Access the full text.
Sign up today, get DeepDyve free for 14 days.
Brown Brown, Metcalf Metcalf, Gough Gough (1994)
Leukemia inhibitory factor and interleukin‐6 are expressed at very low levels in the normal adult mouse and are induced by inflammationGrowth Factors, 6
G. Lynch, R. Hinkle, J. Faulkner (1999)
YEAR‐LONG CLENBUTEROL TREATMENT OF MICE INCREASES MASS, BUT NOT SPECIFIC FORCE OR NORMALIZED POWER, OF SKELETAL MUSCLESClinical and Experimental Pharmacology and Physiology, 26
D. Finkelstein, P. Bartlett, M. Horne, S. Cheema (1996)
Leukemia inhibitory factor is a myotrophic and neurotrophic agent that enhances the reinnervation of muscle in the ratJournal of Neuroscience Research, 46
K. Ikeda, Y. Iwasaki, T. Shiojima, M. Kinoshita (1996)
Neuroprotective effect of various cytokines on developing spinal motoneurons following axotomyJournal of the Neurological Sciences, 135
L. Austin, Antony Burgess (1991)
Stimulation of myoblast proliferation in culture by leukaemia inhibitory factor and other cytokinesJournal of the Neurological Sciences, 101
Carlson Carlson, Shepard Shepard, Komorowski Komorowski (1990)
A histological study of anesthetic‐induced degeneration and regeneration in the monkeyJ Orthop Res, 8
L. Austin, J. Bower, J. Kurek, C. Muldoon (1997)
Controlled release of leukaemia inhibitory factor (LIF) to tissues.Growth factors, 15 1
B. Schoser, Stefan Storjohann, K. Kunze (1998)
Immunolocalization of leukemia inhibitory factor in normal and denervated human muscleNeuroReport, 9
L. Austin, J. Bower, J. Kurek, N. Vakakis (1992)
Effects of leukaemia inhibitory factor and other cytokines on murine and human myoblast proliferationJournal of the Neurological Sciences, 112
K. Ikeda, Y. Iwasaki, N. Tagaya, T. Shiojima, M. Kinoshita (1995)
Neuroprotective effect of cholinergic differentiation factor/leukemia inhibitory factor on wobbler murine motor neuron diseaseMuscle & Nerve, 18
D. Hilton, N. Gough (1991)
Leukemia inhibitory factor: A biological perspectiveJournal of Cellular Biochemistry, 46
J. Kurek, Sara Nouri, G. Kannourakis, M. Murphy, Lawrence Austin (1996)
Leukemia inhibitory factor and interleukin‐6 are produced by diseased and regenerating skeletal muscleMuscle & Nerve, 19
K. Sakuma, Kimi Watanabe, T. Totsuka, I. Uramoto, M. Sano, K. Sakamoto (1998)
Differential adaptations of insulin-like growth factor-I, basic fibroblast growth factor, and leukemia inhibitory factor in the plantaris muscle of rats by mechanical overloading: an immunohistochemical studyActa Neuropathologica, 95
Bruce Carlson, B. Shepard, T. Komorowski (1990)
A histological study of local anesthetic‐induced muscle degeneration and regeneration in the monkeyJournal of Orthopaedic Research, 8
W. Barnard, J. Bower, Melissa Brown, M. Murphy, Lawrence Austin (1994)
Leukemia inhibitory factor (LIF) infusion stimulates skeletal muscle regeneration after injury: Injured muscle expresses lif mRNAJournal of the Neurological Sciences, 123
Bruce Carlson, John Faulkner (1996)
The regeneration of noninnervated muscle grafts and marcaine-treated muscles in young and old rats.The journals of gerontology. Series A, Biological sciences and medical sciences, 51 1
A. Nash, J. Kurek, D. Hilton (1999)
Cytokines: From the laboratory to the clinicDrug Development Research, 46
J. Kurek, J. Bower, M. Romanella, L. Austin (1996)
Leukaemia inhibitory factor treatment stimulates muscle regeneration in the mdx mouseNeuroscience Letters, 212
J. Rosenblatt (1992)
A time course study of the isometric contractile properties of rat extensor digitorum longus muscle injected with bupivacaine.Comparative biochemistry and physiology. Comparative physiology, 101 2
J. Bower, N. Vakakis, N. Nicola, N. Nicola, Lawrence Austin (1995)
Specific binding of leukemia inhibitory factor to murine myoblasts in cultureJournal of Cellular Physiology, 164
We tested the hypothesis that periodic systemic administration of the myogenic cytokine leukemia inhibitory factor (LIF) enhances the functional recovery of regenerating skeletal muscle following bupivacaine‐induced degeneration. LIF had no effect on functional capacity or regenerating myofiber size in rat muscles at 7, 14, or 21 days post‐injury. The results do not support exogenous administration of LIF as a treatment for acute muscle injury, but a more frequent dosing regimen should be tested. © 2000 John Wiley & Sons, Inc. Muscle Nerve 23: 1586–1588, 2000
Muscle and Nerve – Wiley
Published: Oct 1, 2000
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.